Andrew Abe, PharmD

Andrew Abe, PharmD, originally from Mililani Town, Hawaii, earned his undergraduate and PharmD at the University of the Pacific in Stockton, California. He completed a two-year fellowship in Drug Information and Evidence-Based Practice at Creighton University in Omaha, Nebraska. He currently manages the Drug Information Center at the University of Kansas where he is a Clinical Assistant Professor of Pharmacy Practice.
In March 2015, the FDA approved the first biosimilar.
2 years ago
Lymphangioleiomyomatosis is a rare disorder that may progress to respiratory failure or lung degeneration requiring a lung transplant.
3 years ago

Archive

(2)

Most Popular

Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2017
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$